Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S1W-09402 · Session 1

Whether it will make Copaxone available to multiple sclerosis patients through the NHS.

Answered Asked by Murray Tosh Con Lodged 24 Aug 2000

The question

To ask the Scottish Executive whether it will make Copaxone available to multiple sclerosis patients through the NHS.

The answer

Answered by Susan Deacon on 14 Sep 2000 · 21 days after it was lodged, on time

Copaxone (Glatiramer) has been recently licensed for use in the treatment of certain patients with relapsing-remitting multiple sclerosis. It is a matter for each health board to determine its prescribing policy on drugs, taking into account advice from local Drug and Therapeutics Committees.The Health Technology Board for Scotland is at present carrying out an assessment of Beta Interferon and Copaxone in the treatment of multiple sclerosis.

In the Official Report

No contribution in the Official Report cites S1W-09402 by reference.